Hybrid eventIn-person & virtual
March 15–17, 2027Singapore · Village Hotel Changi
3rd Edition
International Cancer & Immuno-Oncology Conference
Submit abstractRegister →

2nd Edition · International Cancer & Immuno-Oncology Conference 2026

March 19–21, 2026 · Singapore

56Speakers
59Presentations
16Countries

About CIOC 2026

The 2nd Edition of the International Cancer & Immuno-Oncology Conference (CIOC 2026), held from March 19–21, 2026 in Singapore, progressed global oncology discussions under the theme “Transforming Cancer Care: Innovations, Integrations, and Impact.” It convened experts from across the medical and research community to share advancements in cancer science, immuno-oncology, and personalized treatment approaches. The event underscored collaborative innovation and evolving clinical strategies to enhance cancer care and patient outcomes worldwide.

Scientific Programme

Day 125 presentations

  1. Personalized and Precision Medicine (PPM) through the view of biodesign-inspired translational research: An option for clinical oncologists, caregivers, and consumers to realize the potential of genomics-informed care to secure human biosafety

    Sergey Suchkov · N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences

  2. Updates on controversies surrounding the staging and management of newly diagnosed localized prostate cancer using Prostate-Specific Membrane Antigen (PSMA) positron emission tomography

    Patricia Tai · University of Saskatchewan

  3. tRNA-derived fragment 3'tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer

    Feng Yan · The Affiliated Cancer Hospital of Nanjing Medical University

  4. Discovery of an R-spondin–ALK–Wnt axis: Expanding the oncogenic landscape of anaplastic lymphoma kinase

    Chockalingam S · National Institute of Technology Warangal

  5. A case-based approach using IMPeTUs criteria in FDG PET/CT reporting of multiple myeloma

    Mudalsha Ravina · All India Institute of Medical Sciences

  6. A pioneering, first-of-its-kind Canadian off-site program designed to reduce the burden on hospital staff and optimize the use of space

    Patricia Tai · University of Saskatchewan

  7. A prospective study of tislelizumab combined with radiotherapy in unresectable or recurrent advanced hepatocellular carcinoma: Efficacy and immunological safety analysis

    Han Sun · Liaoning Cancer Hospital & Institute

  8. Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma

    Jiazhou Ye · Guangxi Medical University Cancer Hospital

  9. Phosphate analog PPF inhibits papillary thyroid cancer by disrupting phosphate balance and reprogramming tumor metabolism

    Yuanhao Su · Second Affiliated Hospital of Xi'an Jiaotong University

  10. Development and validation of a clinical decision-support model for preoperative individualized assessment of high-volume central lymph node metastasis in older adults (over 55 years) with papillary thyroid carcinoma

    Yongke Wu · The Second Affiliated Hospital of Xi’an Jiaotong University

  11. Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance

    Jinyan Feng · Tianjin Medical University Cancer Institute and Hospital

  12. Bevacizumab versus anlotinib respectively combined with chemotherapy drug in the treatment of EGFR-TKI acquired resistant advanced lung adenocarcinoma

    Yanyu Qi · Chengdu Third People's Hospital

  13. Evaluation of survival prognostic factors in different treatment modalities for locally advanced unresectable esophageal squamous cell carcinoma

    Yanni Zhang · Liaoning Cancer Hospital & Institute

  14. Intraocular lymphomas associated with primary CNS lymphomas: Great mystification. Clinical landscape and diagnostic challenges

    Maria S Shmelkova · Burdenko National Research Neurosurgery Center

  15. Personalized and precision oncology via integrating genomics, pathology-related modeling, and IT-assisted approaches to prevent, treat, and cure cancer and its complications

    Sergey Suchkov · N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences

  16. Pleural fluid C-C motif chemokine ligand 2: An effective biomarker for diagnosing malignant pleural effusion

    Li Ma · Beijing Chest Hospital

  17. Programmable enzyme–enabled ultra-sensitive liquid biopsy for early detection of tumor MRD

    Jinzhao Song · Hangzhou Institute of Medicine, Chinese Academy of Sciences

  18. BCL2A1 expression in CD8+ T cells is associated with survival and immune checkpoint blockade response in lung adenocarcinoma

    Hoang Minh Quan Pham · Taipei Medical University

  19. Unmasking the cytokine storm: A spectrum of paediatric hemophagocytic lymphohistiocytosis across immuno-oncologic, infectious, and genetic landscapes - insights from a tertiary oncology centre in South India

    Megadeepan Senthilkumar · Kidwai Memorial Institute of Oncology

  20. Targeting HSD11B2–PD-L1 axis: A novel strategy to reverse immune escape and spontaneous metastasis in renal cell carcinoma

    He Haowei · Jinling Hospital

  21. Identification of prognostic biomarkers and potential therapeutic targets for lung cancer by metabolomics analysis

    Li Su · Harvard T.H. Chan School of Public Health

  22. The oncogenic role of KCNN4 in renal clear cell carcinoma: A mechanism involving immune regulation via Tregs and resting mast cells

    Xiaoming Yi · Jinling Hospital

  23. Phytohormone strigolactams overcome oxaliplatin resistance in colorectal cancer by blocking late-stage autophagy to tip the metabolic balance toward ferroptosis

    Xingyue Chen · Southeast University

  24. Overcoming therapeutic resistance in oncology: A regioselective borylation platform for resurrecting and evolving nucleoside therapeutics

    Yutong Zhou · Southeast University

  25. Temporal changes in HER2 and nectin4 expression in urothelial carcinoma: Implications for antibody–drug conjugate therapy

    Fu Dian · Jinling Hospital

Day 217 presentations

  1. Building bridges: Mechanisms that prevent chromatin bridge breakage in cytokinesis

    George Zachos · University of Cret

  2. The art of patient conversation in oncology

    Stephan Bodis · University Zurich

  3. Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay

    Paulo Cesar De Morais · Catholic University of Brasilia

  4. Multiplexed biosensor detection of cancer biomarkers

    Michael Thompson · University of Toronto

  5. Controlling cells: One nanoparticle at a time

    Thomas Jay Webster · Brown University

  6. A novel blood-based mRNA genomics technology for cancer diagnosis and treatment

    Rajvir Dahiya · University of California San Francisco

  7. The role of emotion regulation, self-compassion, and perceived lifestyle discrepancy in maintaining a healthy lifestyle among breast cancer survivors

    Svetlana Baziliansky · University of Haifa

  8. Radosavljevic's urinary screening biomarkers of the key chemical carcinogens for bladder cancer

    Vladan Radosavljevic · Military Medical Academy

  9. Toll-like receptors-autophagy-PI3Akt “immune-inflammatory metabolic signalosome” in prostate cancer in the robotic prostatectomy golden era: Damage-associated molecular patterns in immunogenic cell-death?

    Saumya Pandey · Indira IVF Hospital

  10. The role of biophysics in cancer

    Ratan Kumar Sarkar · Independent Researcher

  11. Unveiling etiological mechanisms and a targeted, non-toxic integrative approach for cancer management

    Surya Prakash Tadepalli · Jai Surya Global Healthcare Center

  12. Genetic and epigenetic alterations of SOX7 in multiple myeloma and allied neoplasms

    Can Küçük · Dokuz Eylul University

  13. Investigation of new synthetic compounds: 4-(methyl sulfanyl) phenyl-1,3,4-thiadiazol-2-amine and 1-methyl-[4-(methyl sulfanyl)phenyl]-1,3,4-thiadiazol-2-amine, for anti-cancerous activity and for p53 anti-cancer gene expression on glioblastoma cell cultures (LN-229)

    Prabha Muddobalaiah · Ramaiah Institute of Technology

  14. Emerging dynamics of pediatric oncology in India: A systematic meta-analysis of environmental toxins, nutritional deficits and global healthcare disparities

    N D Vaswani · PGIMS, Rohtak

  15. Cancer awareness in teens: A hybrid cross-sectional survey and informational campaign

    Alessandra Storm Mauricio · Christian Brothers High School

  16. AI guided navigation of high risk incidental findings on imaging studies leads to cancer diagnoses

    Kylie Dickerson · University of Arizona College of Medicine Phoenix

  17. Clinical interpretation of whole genome sequencing to assess radiation treatment effects

    K R Muralidhar · Karkinos Healthcare Private Limited

Day 317 presentations

  1. Nasopharyngeal carcinoma: A “different” head and neck tumour

    Pietro Salvatori · Formerly, Humanitas San Pio X Hospital

  2. Theranostic nanoparticles combined particle therapy

    Sandrine Lacombe · University of Paris-Saclay

  3. Deep systems insights into the conceptual breakthrough of the noncoding RNA functional network and its role in cancer

    Anyou Wang · DIFIBER LLC

  4. MicroRNA expression in pediatric sarcoma

    Atif A Ahmed · Seattle Children’s Hospital

  5. A new sensing mechanism for chromatin bridges by the abscission checkpoint in human cancer cells

    Eleni Petsalaki · University of Crete

  6. Reconstruction after salvage surgery for laryngo-pharyngo-esophageal tumors: The experience of the National Cancer Institute of Milan, Italy (1970–2010)

    Pietro Salvatori · Formerly, Humanitas San Pio X Hospital

  7. Platinum micromotors for mucosal penetration and colorectal cancer therapy

    Jun Zhang · The Second Affiliated Hospital of Chongqing Medical University

  8. Ultrasound-guided high-intensity focused ultrasound ablation for pancreatic cancer: Follow-up and clinical analysis

    Jin Chengbing · The Second Affiliated Hospital of Chongqing Medical University

  9. Lifestyle, reproductive factors, and gene expression patterns in breast cancer among rural Indian women

    Neetu Kalra · Azim Premji University

  10. Impact of diclofenac on expression of POTE family genes POTE E and POTE B in epithelial ovarian cancer cell lines

    Keerthi Teja · All India Institute of Medical Sciences New Delhi

  11. Osteopontin-induced M2 macrophage polarization via PI3K/AKT/mTOR signaling in melanoma and its inhibition by andrographolide

    Venketesh K Panda · Kalinga Institute of Industrial Technology, KIIT Deemed to be University

  12. Early nursing recognition and management of oncologic emergencies: A scoping review of emergency and supportive/palliative care approaches

    Omar Alqaisi · Al-Zaytoonah University

  13. Effect of Posaconazole compared to other antifungal drugs in survival & prevention of infection in patients with haematological malignancy: A systematic review

    Arthi Roy · Pabna Medical College

  14. Bio-inspired optimization and AI interpretability for melanoma classification

    Sabura Banu Urundai Meeran · Saveetha Engineering College

  15. Cancer care challenges in Gaza under crisis conditions: Field experience from an oncology nurse

    Mostafa Mesbah Mahmoud Sabbah · Gaza Oncology Center

  16. Uncovering tumor-suppressive roles of histone modifiers in gastric cancer through spatial transcriptomics and epigenomics

    Shilpa S Dhar · The University of Texas at MD Anderson Cancer Center

  17. PD-1 inhibitor-induced refractory Acute Inflammatory Demyelinating Polyneuropathy (AIDP): Case report

    Alec N A Jotte · RUSH MD Anderson Cancer Center

View the full 2026 programme →

Speakers

Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco · United States

Shilpa S Dhar

Shilpa S Dhar

The University of Texas at MD Anderson Cancer Center · United States

Kylie Dickerson

Kylie Dickerson

University of Arizona College of Medicine Phoenix · United States

Sergey Suchkov

Sergey Suchkov

N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences · Russian Federation

Li Su

Li Su

Harvard T.H. Chan School of Public Health · United States

Maria S Shmelkova

Maria S Shmelkova

Burdenko National Research Neurosurgery Center · Russian Federation

Jiazhou Ye

Jiazhou Ye

Guangxi Medical University Cancer Hospital · China

Feng Yan

Feng Yan

The Affiliated Cancer Hospital of Nanjing Medical University · China

Jin Chengbing

Jin Chengbing

The Second Affiliated Hospital of Chongqing Medical University · China

Jinzhao Song

Jinzhao Song

Hangzhou Institute of Medicine, Chinese Academy of Sciences · China

Jinyan Feng

Jinyan Feng

Tianjin Medical University Cancer Institute and Hospital · China

Han Sun

Han Sun

Liaoning Cancer Hospital & Institute · China

Yanni Zhang

Yanni Zhang

Liaoning Cancer Hospital & Institute · China

Jun Zhang

Jun Zhang

The Second Affiliated Hospital of Chongqing Medical University · China

Yongke Wu

Yongke Wu

The Second Affiliated Hospital of Xi’an Jiaotong University · China

Yuanhao Su

Yuanhao Su

Second Affiliated Hospital of Xi'an Jiaotong University · China

Yanyu Qi

Yanyu Qi

Chengdu Third People's Hospital · China

Li Ma

Li Ma

Beijing Chest Hospital · China

Keerthi Teja

Keerthi Teja

All India Institute of Medical Sciences New Delhi · India

Venketesh K Panda

Venketesh K Panda

Kalinga Institute of Industrial Technology, KIIT Deemed to be University · India

All 2026 speakers →

Scientific Committee

Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco · United States

Sergey Suchkov

Sergey Suchkov

N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences · Russian Federation

All 2026 committee members →

Gallery

Cancer ConferenceCancer ConferenceCancer ConferenceCancer ConferenceCancer ConferenceCancer ConferenceCancer ConferenceCancer Conference

All 55 photos from CIOC 2026 →

Videos

CIOC 2026Arthi RoyPabna Medical College · Bangladesh
CIOC 2026Alessandra Storm MauricioChristian Brothers High School · United States
CIOC 2026Saumya PandeyIndira IVF Hospital · India
CIOC 2026Ratan Kumar SarkarIndependent Researcher · India
CIOC 2026Paulo Cesar De MoraisCatholic University of Brasilia · Brazil
CIOC 2026Megadeepan Senthil KumarPaediatric Oncologist, Kidwai Memorial Institute of Oncology, Bengaluru · India
CIOC 2026Can KucukDokuz Eylül University · Turkey
CIOC 2026Stephan BodisUniversity of Zurich · Switzerland
CIOC 2026Svetlana BazilianskyUniversity of Haifa · Israel

All conference videos →

Downloads

Abstract BookCIOC 2026 · PDF ↗Event ProgrammeCIOC 2026 · PDF ↗

3rd Edition · CIOC 2027

March 15–17, 2027 · Village Hotel Changi, Singapore. Registration and abstract submission are open.

Register for CIOC 2027 →

Join the CIOC 2027 delegation

Singapore · March 15–17, 2027· Hybrid · in-person & virtual

Register as Delegate →

Attend without presenting.

Chat with us